TC21 Causes Transformation by Raf-independent Signaling Pathways
Overview
Affiliations
Although the Ras-related protein TC21/R-Ras2 has only 55% amino acid identity with Ras proteins, mutated forms of TC21 exhibit the same potent transforming activity as constitutively activated forms of Ras. Therefore, like Ras, TC21 may activate signaling pathways that control normal cell growth and differentiation. To address this possibility, we determined if regulators and effectors of Ras are also important for controlling TC21 activity. First, we determined that Ras guanine nucleotide exchange factors (SOS1 and RasGRF/CDC25) synergistically enhanced wild-type TC21 activity in vivo and that Ras GTPase-activating proteins (GAPs; p120-GAP and NF1-GAP) stimulated wild-type TC21 GTP hydrolysis in vitro. Thus, extracellular signals that activate Ras via SOS1 activation may cause coordinate activation of Ras and TC21. Second, we determined if Raf kinases were effectors for TC21 transformation. Unexpectedly, yeast two-hybrid binding analyses showed that although both Ras and TC21 could interact with the isolated Ras-binding domain of Raf-1, only Ras interacted with full-length Raf-1, A-Raf, or B-Raf. Consistent with this observation, we found that Ras- but not TC21-transformed NIH 3T3 cells possessed constitutively elevated Raf-1 and B-Raf kinase activity. Thus, Raf kinases are effectors for Ras, but not TC21, signaling and transformation. We conclude that common upstream signals cause activation of Ras and TC21, but activated TC21 controls cell growth via distinct Raf-independent downstream signaling pathways.
Czyzyk D, Yan W, Messing S, Gillette W, Tsuji T, Yamaguchi M Nat Commun. 2025; 16(1):525.
PMID: 39788953 PMC: 11718114. DOI: 10.1038/s41467-024-55766-x.
Classical RAS proteins are not essential for paradoxical ERK activation induced by RAF inhibitors.
Lai L, Fer N, Burgan W, Wall V, Xu B, Soppet D Proc Natl Acad Sci U S A. 2022; 119(5).
PMID: 35091470 PMC: 8812530. DOI: 10.1073/pnas.2113491119.
Weber S, Brossier N, Prechtl A, Barnes S, Wilson L, Brosius S Cell Commun Signal. 2021; 19(1):95.
PMID: 34530870 PMC: 8447793. DOI: 10.1186/s12964-021-00773-4.
Germline-Activating RRAS2 Mutations Cause Noonan Syndrome.
Niihori T, Nagai K, Fujita A, Ohashi H, Okamoto N, Okada S Am J Hum Genet. 2019; 104(6):1233-1240.
PMID: 31130285 PMC: 6562005. DOI: 10.1016/j.ajhg.2019.04.014.
Concepts and advances in cancer therapeutic vulnerabilities in RAS membrane targeting.
Michael J, Goldfinger L Semin Cancer Biol. 2017; 54:121-130.
PMID: 29203271 PMC: 5984110. DOI: 10.1016/j.semcancer.2017.11.021.